We and others have demonstrated that CD163+ M2-like tumor-associated macrophages (TAMs) affect the prognosis of HNSCC [12, 22], but the roles played by CD163– TAMs in antitumor responses remain unclear. The gene discussed is CD163; the disease is neoplasm.